Literature DB >> 9126807

Photosensitization of experimental hepatocellular carcinoma with protoporphyrin synthesized from administered delta-aminolevulinic acid: studies with cultured cells and implanted tumors.

N G Egger1, J A Schoenecker, W K Gourley, M Motamedi, K E Anderson, S A Weinman.   

Abstract

BACKGROUND/AIMS: Photodynamic therapy using porphyrins or related compounds and laser light is an investigational treatment for neoplasms. The aim of this study was to establish whether this might be applicable for hepatocellular carcinoma using protoporphyrin synthesized in the tissue from administered delta-aminolevulinic acid.
METHODS: We measured porphyrin accumulation in normal rat hepatocytes and Morris hepatoma cells in culture, and in subcutaneously implanted hepatomas and other tissues of the rat after administration of delta-aminolevulinic acid, and assessed cell and tissue damage after application of laser light.
RESULTS: Porphyrin accumulation after delta-aminolevulinic acid was added to the medium was greater and continued to increase for a longer period of time in hepatoma cells than in hepatocytes (1337+/-42 vs 513+/-31 fluorescence units/cell at 8 h, means+/-SE, p<0.001). After intraperitoneal injection of delta-aminolevulinic acid to rats with subcutaneously growing hepatomas, porphyrin content in tumor and liver was similar at 4 h but was higher in tumor at 6 h. Laser light caused necrosis of normal and malignant liver cells in culture and subcutaneous hepatomas in vivo.
CONCLUSIONS: We conclude from these in vitro and in vivo studies that porphyrin accumulation after administration of delta-aminolevulinic acid in this hepatoma is substantial and time dependent, and delivery of laser light locally can cause tumor photosensitization and necrosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126807     DOI: 10.1016/s0168-8278(97)80260-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors.

Authors:  Charlotte Benoit; Aurélie Rodrigues; Julien Calderaro; Cécile Charpy; Sylvie Simonin; Jean-Charles Deybach; Laurent Gouya; Hervé Puy; Caroline Schmitt; René Farcy; Valérie Vilgrain; Valérie Paradis; Nicolas Pote; Fouad Lafdil; Sébastien Mule; Emmanuel Itti; Alain Luciani
Journal:  Eur Radiol       Date:  2021-10-25       Impact factor: 5.315

2.  Pu-18-N-butylimide-NMGA-GNP conjugate is effective against hepatocellular carcinoma.

Authors:  Jin-Geun Kwon; In-Sung Song; Min-Soo Kim; Beom Hee Lee; Jung Hwa Kim; Il Yoon; Young Key Shim; Nari Kim; Jin Han; Jae Boum Youm
Journal:  Integr Med Res       Date:  2013-06-13

3.  Theranostic Nanodots with Aggregation-Induced Emission Characteristic for Targeted and Image-Guided Photodynamic Therapy of Hepatocellular Carcinoma.

Authors:  Yang Gao; Qi Chang Zheng; Shidang Xu; Youyong Yuan; Xiang Cheng; Shuai Jiang; Qihong Yu; Zifang Song; Bin Liu; Min Li
Journal:  Theranostics       Date:  2019-02-12       Impact factor: 11.556

4.  Photodynamic therapy: A next alternative treatment strategy for hepatocellular carcinoma?

Authors:  Feng Zhu; Bi-Rong Wang; Zheng-Feng Zhu; Si-Qin Wang; Chu-Xing Chai; Dan Shang; Min Li
Journal:  World J Gastrointest Surg       Date:  2021-12-27

Review 5.  Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go.

Authors:  Kunpeng Wang; Cong Wang; Hao Jiang; Yaqiong Zhang; Weidong Lin; Jinggang Mo; Chong Jin
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

6.  Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma.

Authors:  M Otake; M Nishiwaki; Y Kobayashi; S Baba; E Kohno; T Kawasaki; Y Fujise; H Nakamura
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.